Prajapati, A.; Rangra, S.; Patil, R.; Desai, N.; Jyothi, V.G.S.S.; Salave, S.; Amate, P.; Benival, D.; Kommineni, N.
Receptor-Targeted Nanomedicine for Cancer Therapy. Receptors 2024, 3, 323-361.
https://doi.org/10.3390/receptors3030016
AMA Style
Prajapati A, Rangra S, Patil R, Desai N, Jyothi VGSS, Salave S, Amate P, Benival D, Kommineni N.
Receptor-Targeted Nanomedicine for Cancer Therapy. Receptors. 2024; 3(3):323-361.
https://doi.org/10.3390/receptors3030016
Chicago/Turabian Style
Prajapati, Arvee, Shagun Rangra, Rashmi Patil, Nimeet Desai, Vaskuri G. S. Sainaga Jyothi, Sagar Salave, Prakash Amate, Derajram Benival, and Nagavendra Kommineni.
2024. "Receptor-Targeted Nanomedicine for Cancer Therapy" Receptors 3, no. 3: 323-361.
https://doi.org/10.3390/receptors3030016
APA Style
Prajapati, A., Rangra, S., Patil, R., Desai, N., Jyothi, V. G. S. S., Salave, S., Amate, P., Benival, D., & Kommineni, N.
(2024). Receptor-Targeted Nanomedicine for Cancer Therapy. Receptors, 3(3), 323-361.
https://doi.org/10.3390/receptors3030016